nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature
|
Duricova, Dana |
|
2014 |
|
11 |
p. 1351-1361 11 p. |
artikel |
2 |
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch
|
Werner, Lael |
|
2013 |
|
11 |
p. e522-e532 nvt p. |
artikel |
3 |
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch
|
Pavlidis, Polychronis |
|
2013 |
|
11 |
p. e602-e603 nvt p. |
artikel |
4 |
Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls
|
Bessissow, Talat |
|
2013 |
|
11 |
p. e580-e587 nvt p. |
artikel |
5 |
A randomized clinical trial of mesalazine suppository: The usefulness and problems of central review of evaluations of colonic mucosal findings
|
Kobayashi, Kiyonori |
|
2014 |
|
11 |
p. 1444-1453 10 p. |
artikel |
6 |
Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial
|
Petersen, Andreas Munk |
|
2014 |
|
11 |
p. 1498-1505 8 p. |
artikel |
7 |
Clinical trials in luminal Crohn's disease: A historical perspective
|
Hindryckx, Pieter |
|
2014 |
|
11 |
p. 1339-1350 12 p. |
artikel |
8 |
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study
|
Beigel, Florian |
|
2014 |
|
11 |
p. 1471-1479 9 p. |
artikel |
9 |
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report
|
Turner, Dan |
|
2014 |
|
11 |
p. 1464-1470 7 p. |
artikel |
10 |
Contrast-enhanced ultrasonography for assessment of activity of Crohn's disease: The future?
|
Magalhães, Joana |
|
2013 |
|
11 |
p. e607- 1 p. |
artikel |
11 |
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
|
Ma, Christopher |
|
2014 |
|
11 |
p. 1454-1463 10 p. |
artikel |
12 |
Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale
|
Czuber-Dochan, Wladyslawa |
|
2014 |
|
11 |
p. 1398-1406 9 p. |
artikel |
13 |
Endoscopic biopsy samples of naïve “colitides” patients: Role of basal plasmacytosis
|
Villanacci, Vincenzo |
|
2014 |
|
11 |
p. 1438-1443 6 p. |
artikel |
14 |
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis
|
Koch Hansen, Lars |
|
2014 |
|
11 |
p. 1378-1391 14 p. |
artikel |
15 |
Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis
|
Qiu, Xinyun |
|
2013 |
|
11 |
p. e558-e568 nvt p. |
artikel |
16 |
Family history of inflammatory bowel disease among patients with ulcerative colitis: A systematic review and meta-analysis
|
Childers, Ryan E. |
|
2014 |
|
11 |
p. 1480-1497 18 p. |
artikel |
17 |
Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?
|
Walldorf, Jens |
|
2013 |
|
11 |
p. 901-907 7 p. |
artikel |
18 |
How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures
|
Govani, Shail M. |
|
2013 |
|
11 |
p. 923-927 5 p. |
artikel |
19 |
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
|
Loras, C. |
|
2014 |
|
11 |
p. 1529-1538 10 p. |
artikel |
20 |
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort
|
Vegh, Z. |
|
2014 |
|
11 |
p. 1506-1515 10 p. |
artikel |
21 |
Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: A case report
|
Gibson, D.J. |
|
2014 |
|
11 |
p. 1561-1562 2 p. |
artikel |
22 |
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
|
Wine, Eytan |
|
2013 |
|
11 |
p. 916-922 7 p. |
artikel |
23 |
International variation in medication prescription rates among elderly patients with inflammatory bowel disease
|
Benchimol, Eric I. |
|
2013 |
|
11 |
p. 878-889 12 p. |
artikel |
24 |
Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids
|
Llaó, Jordina |
|
2014 |
|
11 |
p. 1523-1528 6 p. |
artikel |
25 |
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease
|
Maranville, Joseph C. |
|
2014 |
|
11 |
p. 1539-1547 9 p. |
artikel |
26 |
Issue Contents List
|
|
|
2013 |
|
11 |
p. v-vii nvt p. |
artikel |
27 |
Issue Contents list
|
|
|
2014 |
|
11 |
p. v-vii nvt p. |
artikel |
28 |
Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
|
Watanabe, Mamoru |
|
2014 |
|
11 |
p. 1407-1416 10 p. |
artikel |
29 |
May you never forget what is worth remembering: The relation between recall of medical information and medication adherence in patients with inflammatory bowel disease
|
Linn, Annemiek J. |
|
2013 |
|
11 |
p. e543-e550 nvt p. |
artikel |
30 |
Mucosal healing in Crohn's disease — Are we reaching as far as possible with capsule endoscopy?
|
Carvalho, Pedro Boal |
|
2014 |
|
11 |
p. 1566-1567 2 p. |
artikel |
31 |
Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease
|
Lee, Cheng Hiang |
|
2014 |
|
11 |
p. 1551-1556 6 p. |
artikel |
32 |
One size fits all? Choosing the right format to convey statistical information
|
Selinger, Christian P. |
|
2014 |
|
11 |
p. 1565- 1 p. |
artikel |
33 |
On the physician-completed and the patient-completed Simple Clinical Colitis Activity Index (SCCAI)
|
Walmsley, Russell S. |
|
2013 |
|
11 |
p. 930-931 2 p. |
artikel |
34 |
Oral tacrolimus as maintenance therapy for refractory ulcerative colitis—an analysis of outcomes in two London tertiary centres
|
Landy, Jonathan |
|
2013 |
|
11 |
p. e516-e521 nvt p. |
artikel |
35 |
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
|
Sugiura, Toshihiko |
|
2013 |
|
11 |
p. e533-e542 nvt p. |
artikel |
36 |
Portal vein thrombosis after colectomy for ulcerative colitis: Two case reports and proposed novel pathophysiology for this association
|
Mogrovejo, Estela E. |
|
2013 |
|
11 |
p. 933-934 2 p. |
artikel |
37 |
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis
|
Billioud, Vincent |
|
2013 |
|
11 |
p. 853-867 15 p. |
artikel |
38 |
Presenting features and disease course of pediatric ulcerative colitis
|
Aloi, Marina |
|
2013 |
|
11 |
p. e509-e515 nvt p. |
artikel |
39 |
Profile of pediatric Crohn's disease in Belgium
|
De Greef, E. |
|
2013 |
|
11 |
p. e588-e598 nvt p. |
artikel |
40 |
Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease
|
Algaba, Alicia |
|
2013 |
|
11 |
p. e569-e579 nvt p. |
artikel |
41 |
Reply to Dr. Pavlidis et al's letter
|
Werner, Lael |
|
2013 |
|
11 |
p. e604-e605 nvt p. |
artikel |
42 |
Reply to Drs. Walmsley and Casey letter
|
Bennebroek Evertsz', Floor |
|
2013 |
|
11 |
p. 932- 1 p. |
artikel |
43 |
Reply to letter on published paper: Improving quality of care in inflammatory bowel disease: What changes can be made today?
|
Panes, Julian |
|
2014 |
|
11 |
p. 1568- 1 p. |
artikel |
44 |
Response to a letter commenting on “Vitamin D deficiency in Crohn's disease and healthy controls: A prospective case–control study in The Netherlands”
|
de Bruyn, Jessica R. |
|
2014 |
|
11 |
p. 1559-1560 2 p. |
artikel |
45 |
Rising post-colectomy complications in children with ulcerative colitis despite stable colectomy rates in United States
|
Soon, Ing Shian |
|
2014 |
|
11 |
p. 1417-1426 10 p. |
artikel |
46 |
Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: A paradoxical effect
|
Kotze, Paulo Gustavo |
|
2013 |
|
11 |
p. e599-e600 nvt p. |
artikel |
47 |
Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease
|
Mecklenburg, Ingo |
|
2014 |
|
11 |
p. 1392-1397 6 p. |
artikel |
48 |
Should we treat asymptomatic patients with mildly ulcerated terminal ileum?
|
Marques dos Santos, Carlos Hernique |
|
2013 |
|
11 |
p. e601- 1 p. |
artikel |
49 |
Sick leave and disability pension in inflammatory bowel disease: A systematic review
|
Büsch, Katharina |
|
2014 |
|
11 |
p. 1362-1377 16 p. |
artikel |
50 |
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience
|
Kopylov, U. |
|
2014 |
|
11 |
p. 1516-1522 7 p. |
artikel |
51 |
Superficial abdominal thrombophlebitis (Mondor's disease) presenting as loss of response to adalimumab in a Crohn's disease patient
|
Ben-Horin, Shomron |
|
2014 |
|
11 |
p. 1557-1558 2 p. |
artikel |
52 |
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients
|
Protic, Marijana |
|
2014 |
|
11 |
p. 1427-1437 11 p. |
artikel |
53 |
The IMPACT-III (HR) Questionnaire: A valid measure of health-related quality of life in Croatian children with inflammatory bowel disease
|
Abdovic, Slaven |
|
2013 |
|
11 |
p. 908-915 8 p. |
artikel |
54 |
The importance of IGRA in patients candidates for biological therapy
|
Cotter, José |
|
2013 |
|
11 |
p. 928-929 2 p. |
artikel |
55 |
The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers
|
Bennebroek Evertsz', Floor |
|
2013 |
|
11 |
p. 890-900 11 p. |
artikel |
56 |
The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: A follow-up of 20years
|
Manninen, Pia |
|
2013 |
|
11 |
p. e551-e557 nvt p. |
artikel |
57 |
The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: A systematic review and meta-analysis
|
Rosenfeld, Greg |
|
2013 |
|
11 |
p. 868-877 10 p. |
artikel |
58 |
Treatment of inflammatory bowel disease with methotrexate in clinical practice
|
Magalhães, Ricardo Küttner |
|
2013 |
|
11 |
p. e606- 1 p. |
artikel |
59 |
Varicella zoster exposure in IBD patients: Rethink the rash decision
|
Limdi, Jimmy K. |
|
2014 |
|
11 |
p. 1563-1564 2 p. |
artikel |
60 |
Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization
|
Danese, Silvio |
|
2014 |
|
11 |
p. 1548-1550 3 p. |
artikel |